Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Female Infertility Market, and What Factors Will Drive It?
The market size for female infertility has seen continual growth over recent years. The forecast for growth shows an increase from $1.79 billion in 2024 to $1.86 billion in 2025, with a compound annual growth rate (CAGR) of 4.2%. The growth observed in the historic period can be credited to an increasing trend of women choosing to have children later in life, emerging changes in lifestyle, amplified government programs, an escalating aging population, and increased utilization of assisted reproductive technology (ART) treatment.
The market size for female infertility, in the upcoming years, is predicted to witness continuous augmentation, reaching $2.18 billion by 2029, with a compound annual growth rate (CAGR) of 4.0%. This projected growth through the forecast period can be accredited to the escalating consciousness about fertility complications, uptick in instances of polycystic ovary syndrome, rising number of uterine anomalies, increasing occurrence of genetic ailments, and growing obesity. Key trends in the forecast span are anticipated to be the progress in preimplantation genetic testing, technological evolution, innovative diagnostic technologies, fertility conservation, and the rise of telemedicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20787&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theFemale Infertility Market?
The rise in cases of infertility is projected to fuel the expansion of the female infertility market. Infertility is characterized as the incapability to get pregnant despite having regular, unprotected sexual intercourse for 12 months. The surge in infertility numbers can be attributed to late pregnancies, alterations in lifestyle, contamination in the environment, a growing number of obesity cases, and heightened stress levels. To manage infertility effectively, it’s necessary to address hormonal, medical, or structural problems that might be impacting fertility, thus increasing the probability of pregnancy and protecting against permanent infertility. For instance, the Human Fertilization and Embryology Authority, a UK’s non-departmental public entity of the Department of Health and Social Care, reported in July 2024 that fertility clinics in the UK licensed by it carried out close to 77,000 fresh and frozen embryo transfer IVF cycles for about 52,500 patients in 2022. More than 90% of these patients underwent treatment with a partner, involving nearly 100,000 individuals. Consequently, the rise in infertility instances accelerates the expansion of the female infertility market.
Which Segments in the Female Infertility Offer the Most Growth?
The female infertilitymarket covered in this report is segmented –
1) By Treatment: Clomiphene Citrate; Gonadotropins; Metformin; Letrozole; Bromocriptine
2) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
3) By End-User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Clomiphene Citrate: Oral Clomiphene Citrate; Injectable Clomiphene Citrate
2) By Gonadotropins: Recombinant Gonadotropins; Urinary Gonadotropins; Human Chorionic Gonadotropin (hCG)
3) By Metformin: Immediate-Release Metformin; Extended-Release Metformin
4) By Letrozole: Oral Letrozole Tablets; Injectable Letrozole
5) By Bromocriptine: Oral Bromocriptine Tablets; Intranasal Bromocriptine
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20787&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theFemale Infertility Market?# Market?
Europe was the largest region in the female infertility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the female infertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Female Infertility Industry?
Leading enterprises in the female infertility market are concentrating on the creation of novel products, such as non-invasive diagnostic examinations, to gain a competitive industry advantage. A non-invasive diagnostic examination is a form of medical testing used to identify conditions or diseases without the need for surgical procedures or body penetration. For example, in August 2024, Heranova Lifesciences, a biotech firm based in the United States, introduced an early access program for HerResolve, a non-invasive diagnostic examination for endometriosis. Endometriosis, which affects roughly 200 million women globally, can cause infertility, pain, and bleeding. An accurate diagnosis for many of these women takes between 7-10 years on average from the time symptoms first appear due to a varied symptom display and the invasive element of the most dependable diagnostic tool, exploratory laparoscopic surgery. HerResolve could potentially shorten this diagnostic period from years to months, resulting in improved patient and healthcare results. The primary aim of HerResolve is to considerably reduce this time frame, therefore enhancing medical care and results.
View the full report here:
https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report
What Are the Key Elements That Define the Female Infertility Market?
Female infertility is defined as the inability of a woman to conceive after 12 months of regular, unprotected sexual intercourse (or 6 months for women aged 35 or older) or the inability to carry a pregnancy to term. It is a complex condition resulting from various factors affecting the reproductive system.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20787
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model